• 2001 ~ 2005 Catalog Peptide Custom Syntheses
  • 2006 ~ 2014 Peptide Technology Platform
  • 2015 ~ Peptide Driven Growth
  • Catalog Peptide Custom Syntheses
    2001
    Aug-2001 Found
    2004
    July-2004 1st Building 2800㎡
    Rapid Diagnosis
    2005
    Aug-2005 ISO9001
    2006
    cGMP-
    CFDA certification
    2008
    ISO13485
    - cGMP Audits
    - EHS
    - g-500g API
    - FTE
    - Peptide Design
    2009
    Leuprolide PAI
    2010
    2nd Building expand 1860㎡
    2011
    1st FDA Visit No 483
    - g-2Kg API
    - More 510K
    2012
    2nd FDA Visit No 483
    Lilly Venture
    2014
    3rd Building expand 14865㎡
    3rd FDA Visit No 483
    2016
    4th FDA Visit No 483
    New campus 70,000㎡
    2017
    Triptorelin DMF
    Exenatide DMF